DTIL Price / Book | PRECISION BIOSCIENCES INC

PRECISION BIOSCIENCES INC Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

PRECISION BIOSCIENCES INC price/book ratio for the quarter ending 2026-06-30 was 4.6, a 220.22% increase year-over-year.
PRECISION BIOSCIENCES INC price/book ratio for the quarter ending 2026-03-31 was 1.87, a 83.20% increase year-over-year.
PRECISION BIOSCIENCES INC price/book ratio for the quarter ending 2025-12-31 was 1.08, a 95.31% increase year-over-year.
PRECISION BIOSCIENCES INC price/book ratio for the quarter ending 2025-09-30 was 4.02, a 288.75% increase year-over-year.
PRECISION BIOSCIENCES INC price/book ratio for fiscal 2026 was 4.6.
PRECISION BIOSCIENCES INC price/book ratio for fiscal 2025 was 1.08, a 95.31% increase from fiscal 2024.
PRECISION BIOSCIENCES INC price/book ratio for fiscal 2024 was 0.55, a 77.08% decline from fiscal 2023.
PRECISION BIOSCIENCES INC price/book ratio for fiscal 2023 was 2.42, a 10.64% increase from fiscal 2022.

Available history: 2019-03-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	4.6	$208.16M	$45.29M
2026-03-31	1.87	$142.19M	$76.1M
2025-12-31	1.08	$99.85M	$92.25M
2025-09-30	4.02	$66.82M	$16.63M
2025-06-30	1.44	$48.88M	$34.05M
2025-03-31	1.02	$50.32M	$49.34M
2024-12-31	0.55	$31.25M	$56.39M
2024-09-30	1.03	$67.03M	$64.87M
2024-06-30	0.93	$69.31M	$74.71M
2024-03-31	2.52	$93.78M	$37.21M
2023-12-31	2.42	$45.6M	$18.86M
2023-09-30	40.72	$1.18B	$29.06M
2023-06-30	53.34	$1.82B	$34.04M
2023-03-31	63.25	$2.54B	$40.18M
2022-12-31	2.18	$132.04M	$60.43M
2022-09-30	51.27	$4.33B	$84.38M
2022-06-30	51.62	$5.32B	$103.02M
2022-03-31	81.94	$5.71B	$69.66M
2021-12-31	148.3	$13.52B	$91.17M
2021-09-30	205.04	$20.8B	$101.44M
2021-06-30	221.44	$22.27B	$100.55M
2021-03-31	302.06	$17.77B	$58.82M
2020-12-31	296.76	$13.18B	$44.43M
2020-09-30	151.94	$9.7B	$63.82M
2020-06-30	152.3	$13.04B	$85.6M
2020-03-31	80.9	$9.31B	$115.03M
2019-12-31	154.12	$21.32B	$138.31M
2019-09-30	81.85	$12.75B	$155.79M
2019-06-30	115.59	$20.11B	$173.98M
2019-03-31	798.18	$8.64B	$10.83M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	4.6	$208.16M	$45.29M
2025-12-31	1.08	$99.85M	$92.25M
2024-12-31	0.55	$31.25M	$56.39M
2023-12-31	2.42	$45.6M	$18.86M
2022-12-31	2.18	$132.04M	$60.43M
2021-12-31	148.3	$13.52B	$91.17M
2020-12-31	296.76	$13.18B	$44.43M
2019-12-31	154.12	$21.32B	$138.31M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Voyager Therapeutics, Inc. (VYGR)	United States	$0.173B	-1.99
Coherus Oncology, Inc. (CHRS)	United States	$0.182B	-1.63
Alpha Cognition Inc. (ACOG)		$0.185B	-6.77
Acumen Pharmaceuticals, Inc. (ABOS)	United States	$0.162B	-1.83
Outlook Therapeutics, Inc. (OTLK)	United States	$0.162B	-4.90
Humacyte, Inc. (HUMA)	United States	$0.155B	-2.26
Protara Therapeutics, Inc. (TARA)	United States	$0.198B	-3.22
Compass Therapeutics, Inc. (CMPX)	United States	$0.204B	-5.35
Tenaya Therapeutics, Inc. (TNYA)	United States	$0.140B	-1.60
Alector, Inc. (ALEC)	United States	$0.213B	-1.90